Cross-institution positioning
Aug 14, 2026Strong institutional reduction. 3 reducing, 3 exited across 6 comparable institutions.
Source: Schedule 13 researchTELEFLEX INC
Latest stored close $124.48 as of Oct 7, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Strong institutional reduction. 3 reducing, 3 exited across 6 comparable institutions.
Source: Schedule 13 research1 increased/new, 1 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsRecent Forms 3/4/5 activity is available, with no non-amendment non-derivative SEC-coded P/S transactions in the rolling 90-day window. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/54 non-amendment material events in the last 90 days; Latest classified evidence: Director or executive change. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +28.9% YoY; Net income -18.7% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 64% through its reported 52-week range; +2.5% over one year.
Source: Stored historical price seriesFiled Aug 14, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Salmon Sean | AGrant, award, or other acquisition · derivative | Stock Option / (Right to Buy) | 4.4K | $0.00 | Direct | Sep 10, 2026 |
| Sep 8, 2026 | Salmon Sean | AGrant, award, or other acquisition | Common Stock | 674 | $0.00 | Direct | Sep 10, 2026 |
| Jun 8, 2026 | RANDLE STUART A | AGrant, award, or other acquisition · derivative | Stock Option / (Right to Buy) | 2.2K | $0.00 | Direct | Jun 9, 2026 |
| Jun 8, 2026 | RANDLE STUART A | AGrant, award, or other acquisition | Common Stock | 4.7K | $0.00 | Direct | Jun 9, 2026 |
| Jun 8, 2026 | RANDLE STUART A | AGrant, award, or other acquisition | Common Stock | 995 | $0.00 | Direct | Jun 9, 2026 |
| Jun 8, 2026 | Weidman Jason R. | AGrant, award, or other acquisition · derivative | Stock Option / (Right to Buy) | 26.1K | $0.00 | Direct | Jun 9, 2026 |
| Jun 8, 2026 | Weidman Jason R. | AGrant, award, or other acquisition | Common Stock | 54.0K | $0.00 | Direct | Jun 9, 2026 |
| Jun 7, 2026 | RANDLE STUART A | FTax/price withholding or payment | Common Stock | 4.1K | $129.84 | Direct | Jun 9, 2026 |
| May 15, 2026 | Ryu Jaewon | AGrant, award, or other acquisition · derivative | Stock Option / (Right to Buy) | 2.4K | $0.00 | Direct | May 19, 2026 |
| May 15, 2026 | Ryu Jaewon | AGrant, award, or other acquisition | Common Stock | 1.1K | $0.00 | Direct | May 19, 2026 |
| May 15, 2026 | Krakauer Andrew A | AGrant, award, or other acquisition · derivative | Stock Option / (Right to Buy) | 2.4K | $0.00 | Direct | May 19, 2026 |
| May 15, 2026 | Krakauer Andrew A | AGrant, award, or other acquisition | Common Stock | 1.1K | $0.00 | Direct | May 19, 2026 |
| May 15, 2026 | HAGGERTY GRETCHEN R | AGrant, award, or other acquisition · derivative | Stock Option / (Right to Buy) | 2.4K | $0.00 | Direct | May 19, 2026 |
| May 15, 2026 | HAGGERTY GRETCHEN R | AGrant, award, or other acquisition | Common Stock | 1.1K | $0.00 | Direct | May 19, 2026 |
| May 15, 2026 | Duncan Candace H | AGrant, award, or other acquisition · derivative | Stock Option / (Right to Buy) | 2.4K | $0.00 | Direct | May 19, 2026 |
| May 15, 2026 | Duncan Candace H | AGrant, award, or other acquisition | Common Stock | 1.1K | $0.00 | Direct | May 19, 2026 |
| May 15, 2026 | TOKICH MICHAEL J | AGrant, award, or other acquisition · derivative | Stock Option / (Right to Buy) | 4.8K | $0.00 | Direct | May 19, 2026 |
| May 15, 2026 | TOKICH MICHAEL J | AGrant, award, or other acquisition | Common Stock | 1.1K | $0.00 | Direct | May 19, 2026 |
| May 15, 2026 | Patil Neena M | AGrant, award, or other acquisition · derivative | Stock Option / (Right to Buy) | 2.4K | $0.00 | Direct | May 19, 2026 |
| May 15, 2026 | Patil Neena M | AGrant, award, or other acquisition | Common Stock | 1.1K | $0.00 | Direct | May 19, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Sep 9, 2026 | 8-K | 5.02, 7.01, 9.01 | Director or executive change; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Aug 7, 2026 | 8-K | 8.01 | Other event | — | Filing |
| Aug 6, 2026 | 8-K | 2.02, 7.01, 9.01 | Results of operations / financial condition; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Aug 5, 2026 | 8-K/AAmendment | 9.01 | Financial statements / exhibits | — | Filing |
| Aug 3, 2026 | 8-K | 2.01, 7.01, 9.01 | Acquisition or disposition of assets; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Jun 15, 2026 | 8-K | 1.01, 2.03, 9.01 | Material definitive agreement; New direct financial obligation; Financial statements / exhibits | Debt | Filing |
| Jun 9, 2026 | 8-K | 5.02 | Director or executive change | — | Filing |
| Jun 2, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Jun 1, 2026 | 8-K | 7.01, 8.01, 9.01 | Regulation FD disclosure; Other event; Financial statements / exhibits | — | Filing |
| May 27, 2026 | 8-K | 1.01, 2.03, 9.01 | Material definitive agreement; New direct financial obligation; Financial statements / exhibits | Debt | Filing |
| May 20, 2026 | 8-K | 5.07 | Shareholder vote results | — | Filing |
| May 7, 2026 | 8-K | 2.02, 7.01, 9.01 | Results of operations / financial condition; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 30, 2026 | $570.3M | +28.9% |
| Ended Mar 31, 2026 | $548.3M | +32.3% |
| Ended Dec 31, 2025 | $569.0M | +28.7% |
| Ended Sep 28, 2025 | $566.9M | +33.0% |
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 31, 2025 | $2.0B | +17.2% |
| Ended Dec 31, 2024 | $1.7B | -0.8% |
| Ended Dec 31, 2023 | $1.7B | -38.6% |
| Ended Dec 31, 2022 | $2.8B | -0.7% |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Investment Management CIK0001897612 | Jun 30, 2026 observed Aug 14, 2026 filed · 45d Schedule 13G amendment | Reported reduction | 3.2M -641.5K | 7.20% -4.80 pts | $126.76 | $137.17 | $124.48 |
| Vanguard Capital Management CIK0002100119 | Jun 30, 2026 quarter end Aug 13, 2026 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 2.0M | $124.48 | |||
| T. Rowe Price Investment Management CIK0001897612 | Mar 31, 2026 observed May 15, 2026 filed · 45d Schedule 13G amendment | Reported reduction | 3.8M -732.8K | 12.00% 0.00 pts | $119.61 | $129.71 | $124.48 |
Compare TFX with other securities showing similar institutional activity or recent accumulation across several tracked institutions.